Source: ukhealthexpert.com
Insys Therapeutics announced that the United States Food and Drug Administration had granted orphan drug designation to its proprietary cannabidiol product for the treatment of glioma. (A glioma is a type of tumor that starts in the brain or spine.) To be granted orphan drug designation, the pharmaceutical must…
